I've been collaborating for several months in the Rosetta project yielding time of my CPU.
However, I have recently a big doubt. Although I trust in the good intentions pursued with this project, I wonder if there is any real possibility of that progress to be made as a consecuence of this investigation does not fall into the hands of multinational pharmaceutical private sector. Would it be possible that, finally, all these advances allow, once again, these companies get rich at the expense of TRIPS patents?
Regards,

Juanma

I've been collaborating for several months in the Rosetta project yielding time of my CPU.
However, I have recently a big doubt. Although I trust in the good intentions pursued with this project, I wonder if there is any real possibility of that progress to be made as a consecuence of this investigation does not fall into the hands of multinational pharmaceutical private sector. Would it be possible that, finally, all these advances allow, once again, these companies get rich at the expense of TRIPS patents?
Regards,

Juanma

Don't worry--all the results have been and will continue to be in the public domain. In fact, I am not allowed to accept any funding from private companies as the Howard Hughes Medical Institute, which funds my research, expressly forbids this. (and I think it is a good thing). so no private company has any rights or control whatsoever on the results from rosetta@home.

---

Don't worry--all the results have been and will continue to be in the public domain. In fact, I am not allowed to accept any funding from private companies as the Howard Hughes Medical Institute, which funds my research, expressly forbids this. (and I think it is a good thing). so no private company has any rights or control whatsoever on the results from rosetta@home.

I love to know that.
Thanks a lot.

Don't worry--all the results have been and will continue to be in the public domain. In fact, I am not allowed to accept any funding from private companies as the Howard Hughes Medical Institute, which funds my research, expressly forbids this. (and I think it is a good thing). so no private company has any rights or control whatsoever on the results from rosetta@home.

I love to know that.
Thanks a lot.

Bringing drug to market is costly and risky business. That require huge investments. And if any drug designed with a help of Rosetta software would be successful, sure it will eventually pay to those guys who helped to become it possible. Thus making money to big or small pharmaceutical(and their investors).

And don't forget, Rosetta software, as most of scientific advances published in journals, are available to private sector for development. In fact BakerLab distribute Rosetta free for academic use, but sells it to private companies.